These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36643886)

  • 1. The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions.
    Gazeau S; Deng X; Ooi HK; Mostefai F; Hussin J; Heffernan J; Jenner AL; Craig M
    Immunoinformatics (Amst); 2023 Mar; 9():100021. PubMed ID: 36643886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI-guided discovery of the invariant host response to viral pandemics.
    Sahoo D; Katkar GD; Khandelwal S; Behroozikhah M; Claire A; Castillo V; Tindle C; Fuller M; Taheri S; Rogers TF; Beutler N; Ramirez SI; Rawlings SA; Pretorius V; Smith DM; Burton DR; Alexander LEC; Duran J; Crotty S; Dan JM; Das S; Ghosh P
    bioRxiv; 2021 Apr; ():. PubMed ID: 32995790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.
    Ma L; Li H; Lan J; Hao X; Liu H; Wang X; Huang Y
    Comput Biol Chem; 2021 Dec; 95():107599. PubMed ID: 34773807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins.
    Bachus S; Akkerman N; Fulham L; Graves D; Stephanson C; Memon H; Miller MS; Pelka P
    mSphere; 2022 Apr; 7(2):e0099821. PubMed ID: 35224978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.
    Wang J; Li Q; Qiu Y; Lu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2393-2404. PubMed ID: 36069182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.
    Soni B; Kabra R; Singh S
    J Interferon Cytokine Res; 2021 Jul; 41(7):244-257. PubMed ID: 34280026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regressive Class Modelling for Predicting Trajectories of COVID-19 Fatalities Using Statistical and Machine Learning Models.
    Chowdhury RI; Hasan MT; Sneddon G
    Bull Malays Math Sci Soc; 2022; 45(Suppl 1):235-250. PubMed ID: 35431363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2.
    Rodrigues P; Costa RS; Henriques R
    Comput Biol Med; 2022 Jul; 146():105443. PubMed ID: 35533463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
    Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
    Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.